Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
339
datasets available to search
ShareScore release 0.9.0
Dataset results
339 results for “CML”
Allogeneic SCT for CML, TKI Failure After TKI Failure
ClinicalTrials.gov study NCT02172365. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.
ClinicalTrials.gov study NCT01130688. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Symptom Burden in Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT01046305. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission
ClinicalTrials.gov study NCT03117816. IPD Sharing: NO. Countries: 2. Publications: 60.
Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib Therapy
ClinicalTrials.gov study NCT00858806. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tyrosine Kinase Inhibitor Withdrawal Syndrome in CML Patients: Observatory Trial Studying the Biological Factors.
ClinicalTrials.gov study NCT03996096. IPD Sharing: NO. Countries: 1. Publications: 4.
Chronic Myeloid Leukemia (CML) Real-Life Database
ClinicalTrials.gov study NCT05963061. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
ClinicalTrials.gov study NCT04260022. IPD Sharing: NO. Countries: 2. Publications: 2.
The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CML
ClinicalTrials.gov study NCT02204644. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy
ClinicalTrials.gov study NCT00815321. IPD Sharing: Not stated. Countries: 1. Publications: 12.
A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL
ClinicalTrials.gov study NCT02081378. IPD Sharing: NO. Countries: 10. Publications: 3.
Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS
ClinicalTrials.gov study NCT01159028. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion
ClinicalTrials.gov study NCT00966810. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy
ClinicalTrials.gov study NCT00896129. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)
ClinicalTrials.gov study NCT01774630. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib
ClinicalTrials.gov study NCT02115386. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Pioglityazone and Imatinib for CML Patients
ClinicalTrials.gov study NCT02888964. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation
ClinicalTrials.gov study NCT04666259. IPD Sharing: YES. Countries: 1. Publications: 0.
Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease
ClinicalTrials.gov study NCT00819143. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
ClinicalTrials.gov study NCT00816114. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.